09:13 AM EDT, 07/10/2024 (MT Newswires) -- Health care stocks were steady premarket Wednesday as the Health Care Select Sector SPDR Fund ( XLV ) was up 0.03% and the iShares Biotechnology ETF ( IBB ) was recently inactive.

Illumina ( ILMN ) rose 4% after saying it has acquired Fluent BioSciences, a privately held developer of a highly differentiated single-cell analysis technology.

Evotec (EVO) advanced nearly 4% after saying it has entered a multi-year research collaboration and option agreement with Pfizer ( PFE ) .

Arcutis Biotherapeutics (ARQT) was up nearly 5% after saying the US Food and Drug Administration approved Zoryve to treat mild to moderate atopic dermatitis in adults and pediatric patients six years and older.